Skip to main content
TipRanks
Go Ultimate75% OFF

Syros Pharmaceuticals (0S90) Q2 2023 Earnings Report

2 Followers

DE:0S90 Q2 2023 EPS Results

Actual EPS
-EUR 1.18
Consensus EPS
-EUR 1.02
Beat/Miss
Missed by -EUR 0.16
One Year Ago EPS
-EUR 4.90

DE:0S90 Q2 2023 Revenue Results

Actual Revenue
EUR 2.57M
Expected Revenue
EUR 3.18M
Beat/Miss
Missed by -EUR 605.07K
YoY Revenue Growth
-54.86%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/08/2023
Time
Before Open
Conference Call
Tuesday, August 8, 2023

Q2 2023 Earnings Call Audio

DE:0S90 Q2 2023 Earnings Call
0:00 / 0:00

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:0S90 Earnings History

DE:0S90 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20252025 (Q3)―--0.15―
Jul 31, 20252025 (Q2)-0.21--0.54―
May 01, 20252025 (Q1)-0.34-0.34-0.09-280.00% (-0.25)
Mar 06, 20252024 (Q4)-0.59-0.59-1.9870.18% (+1.39)
Oct 31, 20242024 (Q3)-0.61-0.15-1.388.81% (+1.15)
Jul 31, 20242024 (Q2)-0.70-0.54-1.1854.62% (+0.64)
May 14, 20242024 (Q1)-0.77-0.09-0.7788.24% (+0.68)
Mar 27, 20242023 (Q4)-1.04-1.98-0.15-1182.35% (-1.82)
Nov 14, 20232023 (Q3)-1.03-1.30-2.9155.45% (+1.61)
Aug 08, 20232023 (Q2)-1.02-1.18-4.975.93% (+3.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed